POSC94 Cost-Effectiveness of Risdiplam Versus Nusinersen for Treating Patients with Spinal Muscular Atrophy Type 1 in China.
Saved in:
| Title: | POSC94 Cost-Effectiveness of Risdiplam Versus Nusinersen for Treating Patients with Spinal Muscular Atrophy Type 1 in China. |
|---|---|
| Authors: | Hu, J1 (AUTHOR), Sutherland, CS2 (AUTHOR), Aponte Ribero, V2 (AUTHOR), Zhu, L1 (AUTHOR), Hou, X3 (AUTHOR), Xia, Y4 (AUTHOR), Tang, M4 (AUTHOR), Jin, C1 (AUTHOR), Kang, Q1 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS105-S105. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2021.11.499 |
